Dashboard
Manage Tickers

AZNASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 80.88 $ -2.17 (-2.61 %)    

Monday, 09-Sep-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.28 $ 2.75 (0.61 %)
DIA $ 409.08 $ 1.75 (0.43 %)
SPY $ 546.60 $ 1.93 (0.35 %)
TLT $ 99.96 $ 0.58 (0.58 %)
GLD $ 231.58 $ 0.32 (0.14 %)
$ 83.05
$ 82.23
$ 80.87 x 300
$ 80.91 x 100
$ 79.10 - $ 83.42
$ 58.30 - $ 87.68
5,516,402
na
128.75B
$ 0.56
$ 7.52
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

enliven-therapeutics-leukemia-candidate-could-challenge-pfizer-astrazeneca-in-broader-target-market-analyst
Enliven Therapeutics' Leukemia Candidate C...
09/09/2024 18:05:21

HC Wainwright initiated coverage on Enliven Therapeutics, noting its innovative small molecules for tumor treatments. HC Wainwr...

Core News & Articles
AstraZeneca Says Datopotamab Deruxtecan Sh...
09/09/2024 17:55:38

datopotamab-deruxtecan-shows-median-overall-survival-of-146-months-in-tropion-lung01-phase-iii-trial-for-advanced-nonsquamous-nsclc-results-to-be-presented-at-2024-world-conference-on-lung-cancer
Datopotamab Deruxtecan Shows Median Overal...
09/09/2024 17:51:24

astrazeneca-and-daiichi-sankyos-datopotamab-deruxtecan-demonstrated-meaningfully-greater-magnitude-of-progression-free-survival-benefit-in-non-small-cell-lung-cancer-patients-with-trop2-biomarker-in-tropion-lung01-phase-3-trial
AstraZeneca And Daiichi Sankyo's Datopotam...
09/09/2024 08:04:26

Core News & Articles
Innate Pharma And AstraZeneca Reveal Monal...
09/09/2024 05:58:41

The preliminary data of three arms were presented at WCLC, namely: Arm 1: oleclumab in combination with durvalumab and plati...

astrazeneca-in-trouble-for-employee-detentions-in-china-over-illegal-activities
AstraZeneca In Trouble For Employee Detent...
09/05/2024 17:37:26

Chinese police detain AstraZeneca employees over alleged data privacy breaches and unlicensed drug imports amid an anti-corrupt...

astrazeneca-options-trading-a-deep-dive-into-market-sentiment
AstraZeneca Options Trading: A Deep Dive i...
09/05/2024 16:02:21

china-detains-astrazeneca-staff-in-data-drug-import-probes---bloomberg
'China Detains AstraZeneca Staff in Data, ...
09/05/2024 12:14:37

https://www.bloomberg.com/news/articles/2024-09-05/china-detains-astrazeneca-staff-in-data-drug-import-probes

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs
Despite Medicare Negotiations, Americans M...
09/03/2024 19:12:09

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

astrazeneca-plans-presentations-across-its-portfolio-and-pipeline-at-the-iaslc-2024-world-conference-on-lung-cancer-and-esmo-congress
AstraZeneca Plans Presentations Across Its...
09/03/2024 11:26:53

Across the two meetings, more than 130 abstracts will feature 17 approved and potential new medicines from AstraZeneca includin...

astrazeneca-threatens-to-move-vaccine-production-amid-reduced-state-support
AstraZeneca Threatens To Move Vaccine Prod...
08/23/2024 12:39:24

AstraZeneca may relocate its vaccine manufacturing site from Merseyside to Philadelphia as the UK government considers slashing...

ozempic-and-wegovy-linked-to-increased-suicidal-thoughts-in-observational-study-but-results-are-contested
Ozempic And Wegovy Linked to Increased Sui...
08/20/2024 18:06:17

A recent study in JAMA Network Open raises concerns about a potential link between GLP-1 drugs Ozempic and Wegovy and an increa...

Core News & Articles
WHO Official Hans Kluge Asserts Mpox Is No...
08/20/2024 17:25:45

- Reuters 

johnson--johnson-strikes-17b-deal-to-acquire-heart-tech-innovator-v-wave
Johnson & Johnson Strikes $1.7B Deal To Ac...
08/20/2024 14:31:09

Johnson & Johnson to acquire V-Wave for $600 million with potential $1.1 billion in milestone payments. Deal boosts JNJ Med...

Core News & Articles
China's National Medical Products Associat...
08/20/2024 08:58:34

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
08/19/2024 17:35:23

Core News & Articles
Daiichi Sankyo And AstraZeneca's ENHERTU R...
08/19/2024 06:29:25

Daiichi Sankyo and AstraZeneca's ENHERTU has now been granted eight Breakthrough Therapy Designations with latest based o...

fda-approves-astrazenecas-blockbuster-cancer-drug-imfinzi-in-combination-with-chemo-for-non-small-cell-lung-cancer
FDA Approves AstraZeneca's Blockbuster Can...
08/16/2024 12:51:15

FDA approves AstraZeneca's Imfinzi with chemotherapy for early-stage lung cancer, based on pivotal AEGEAN trial. Imfinzi sh...

Core News & Articles
FDA Approves AstraZeneca's Imfinzi (Durval...
08/16/2024 09:18:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION